M.D. Anderson Cancer Center
This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.
PRIMARY OBJECTIVES: I. Identify patient, provider, and health system factors contributing to the completion of recommended germline testing for men with prostate cancer. II. Develop a decision support tool for patients tailored to the cultural and socioeconomic context of the local community. III. Conduct a pilot intervention trial to evaluate a point-of-care decision support tool in a public safety net hospital in Harris County, Texas. SECONDARY OBJECTIVES: I. Assess the feasibility of point-of-care decision support tool in a public safety net hospital in Harris County, Texas. II. Asses…
Inclusion Criteria: * Diagnosed prostate cancer patients receiving care at Lyndon B. Johnson (LBJ) Hospital * Were recommended for germline genetic testing by their oncology provider * Can provide informed consent * Can communicate in English or Spanish Exclusion Criteria: * Prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition
View decision support tool
Undergo blood sample collection
Ancillary studies
Meet with genetic counselor
Undergo standard of care genetic testing
Complete qualitative interview
Complete cognitive interview
Ancillary studies
Arctuva estimate
Verify or correct the compensation shown for this listing.